SecurityNVTR / Nuvectra Corporation (67075N108)
IndustrySurgical and Medical Instruments and Apparatus
Common Shares Outstanding14,260,449 shares (as of 2018-06-30)
Total Insiders16
Total Directors8
Total Officers8

Stock Insider Trading (from SEC Form 4)

Nuvectra Corporation insider trades are listed in the following table, followed by a table containing the full transaction history. Insiders are officers, directors, or significant investors in a company. In general, it is generally illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.

NVTR / Nuvectra Corporation insiders include Bihl Anthony P III, Tremmel Jon T, Tranchina Benjamin Zelibor Thomas Edward, Kaula Norbert, GREATBATCH, INC., DREES SCOTT F, JOHNSON DAVID D, Hickman Thomas Kelley, BERGER WALTER Z, HAWARI KENNETH G, Kosharek Jennifer, and MILLER JOSEPH A, PARKS FRED B, Fahey Kathy Jo, Hanchin Joseph Paul, .

Insider Roster

Insider Dir Off 10% Shares Owned
Zelibor Thomas Edward Director
X 9,376
Tremmel Jon T Director
X 19,594
PARKS FRED B Director
X 8,376
MILLER JOSEPH A Director
X 46,271
JOHNSON DAVID D Director
X 38,376
HAWARI KENNETH G Director
X 25,376
Bihl Anthony P III Director
X 11,815
BERGER WALTER Z CFO
X 85,337
DREES SCOTT F CEO, Director
X X 205,320
Kosharek Jennifer Principal Accounting Officer
X 3,277
Hanchin Joseph Paul President
X 43,943
Tranchina Benjamin Chief Technology Officer
X
Kaula Norbert EVP, Research & Development
X 15,467
Hickman Thomas Kelley EVP, Sales & Marketing
X 3,442
Fahey Kathy Jo VP of Regulatory & Clinical
X 2,854
GREATBATCH, INC. 10% Owner
X

Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b-5 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Form Insider Code 10b-5 Direct Share
Price
Shares
Changed
Remaining
Shares
Post Value
2018-10-09 4 Bihl Anthony P III M D 23.19 838 11,815
2018-10-09 4 HAWARI KENNETH G M D 23.19 838 25,376
2018-10-09 4 JOHNSON DAVID D M D 23.19 838 38,376
2018-10-09 4 MILLER JOSEPH A M D 23.19 838 46,271
2018-10-09 4 PARKS FRED B M D 23.19 838 8,376
2018-10-09 4 Tremmel Jon T M D 23.19 838 19,594
2018-10-09 4 Zelibor Thomas Edward M D 23.19 838 9,376
2018-10-07 4 Hanchin Joseph Paul M D 24.32 4,273 43,943
2018-10-07 4 Kosharek Jennifer M D 24.32 174 3,277
2018-10-07 4 DREES SCOTT F M D 24.32 16,024 205,320
2018-10-07 4 BERGER WALTER Z M D 24.32 8,012 85,337
2018-10-01 4 Tremmel Jon T M D 6.87 7,868 18,756
2018-10-01 4 Tremmel Jon T M D 6.87 3,350 10,888
2018-08-20 4 Hanchin Joseph Paul S D 20.43 -1,250 39,670 810,458
2018-08-12 4 BERGER WALTER Z M D 18.14 1,036 77,325
2018-08-12 4 Hanchin Joseph Paul M D 18.14 797 40,920
2018-08-12 4 Kaula Norbert M D 18.14 2,141 15,467
2018-08-12 4 Kosharek Jennifer M D 18.14 442 3,103
2018-07-09 4 Zelibor Thomas Edward M D 17.36 838 8,538
2018-07-09 4 Bihl Anthony P III M D 17.36 838 10,977
2018-07-09 4 HAWARI KENNETH G M D 17.36 838 24,538
2018-07-09 4 JOHNSON DAVID D M D 17.36 838 37,538
2018-07-09 4 MILLER JOSEPH A M D 17.36 838 45,433
2018-07-09 4 PARKS FRED B M D 17.36 838 7,538
2018-07-09 4 Tremmel Jon T M D 17.36 838 7,538
2018-07-07 4 BERGER WALTER Z M D 18.09 8,012 76,289
2018-07-07 4 DREES SCOTT F M D 18.09 16,024 189,296
2018-07-07 4 Hanchin Joseph Paul M D 18.09 4,273 40,123
2018-05-17 4 Hanchin Joseph Paul S D 17.33 -1,541 35,850 621,280
2018-07-07 4 Kaula Norbert M D 18.09 499 13,326
2018-07-07 4 Kosharek Jennifer M D 18.09 175 2,661
2018-05-12 4 BERGER WALTER Z M D 16.73 4,141 68,277
2018-05-12 4 Hanchin Joseph Paul M D 16.73 3,185 37,391
2018-05-12 4 Kaula Norbert M D 16.73 8,559 12,827
2018-05-08 4 Zelibor Thomas Edward P D 16.50 1,000 7,700 127,050
2018-04-10 4 Bihl Anthony P III M D 13.53 837 10,139
2018-04-10 4 HAWARI KENNETH G M D 13.53 837 23,700
2018-04-10 4 JOHNSON DAVID D M D 13.53 837 36,700
2018-04-10 4 MILLER JOSEPH A M D 13.53 837 44,595
2018-04-10 4 PARKS FRED B M D 13.53 837 6,700
2018-04-10 4 Tremmel Jon T M D 13.53 837 6,700
2018-04-10 4 Zelibor Thomas Edward M D 13.53 837 6,700
2018-04-07 4 BERGER WALTER Z M D 13.05 8,012 64,136
2018-04-07 4 DREES SCOTT F M D 13.05 16,024 173,272
2018-04-07 4 Hanchin Joseph Paul M D 13.05 4,273 34,206
2018-04-07 4 Kaula Norbert M D 13.05 499 4,268
2018-01-10 4 Bihl Anthony P III M D 9.79 837 9,302
2018-01-10 4 HAWARI KENNETH G M D 9.79 837 22,863
2018-01-10 4 JOHNSON DAVID D M D 9.79 837 35,863
2018-01-10 4 MILLER JOSEPH A M D 9.79 837 43,758
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)

Related News Stories

Implied Volatility Surging for Nuvectra (NVTR) Stock Options

2018-09-24 zacks
Investors in Nuvectra Corporation (NVTR - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Nov 16, 2018 $20.00 Call had some of the highest implied volatility of all equity options today.

Are Options Traders Betting on a Big Move in Nuvectra (NVTR) Stock?

2018-08-21 zacks
Investors in Nuvectra Corporation (NVTR - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Sep 21, 2018 $17.50 Put had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other.

Nuvectra Corporation (NVTR) CEO Scott Drees on Q2 2018 Results - Earnings Call Transcript

2018-08-12 seekingalpha
Good day, ladies and gentlemen, and welcome to the Q2 2018 Nuvectra Earnings Conference Call. [Operator Instructions] As a reminder, this conference call may be recorded. (3-0)

Your Daily Pharma Scoop: Redhill's New Patent, Nuvectra Slips, Teligent Gains

2018-07-03 seekingalpha
RedHill Biopharma (RDHL) announced that two new patents covering Crohn's disease candidate RHB-104 are notified by USPTO and the European Patent Office. The candidate is currently in Phase 3 development. The patents will be in effect until 2029. The company has an important upcoming catalyst related to its RHB-104 candidate. Topline Phase 3 data of RHB-104 trial MAP-US on Crohn's disease expected in early August 2018. (27-2)

Why Nuvectra Is Monday’s Big Biotech Loser

2018-07-02 247wallst
Nuvectra Corp. (NASDAQ: NVTR) shares were crushed on Monday after the company announced an update on its U.S. Food and Drug Administration (FDA) premarket approval (PMA) application and its TÜV SÜD application for CE Mark in Europe for Virtis. (1-0)